FDA Investigator Deborah K Richardson

Deborah K Richardson has inspections in 35 countries as of 28 Nov 2023. Deborah K Richardson has collaborated with a combinined 4087 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
387
Last Inspection Date:
28 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, United Arab Emirates, Spain, Morocco, Viet Nam, Netherlands, South Africa, Ecuador, France, Mexico, Philippines, Peru, Croatia, Italy, Brazil, Ireland, Thailand, Chile, Guatemala, Jamaica, Faroe Islands, Germany, Dominican Republic, China, United Kingdom of Great Britain and Northern Ireland, Taiwan, Japan, Argentina, Indonesia, Canada, India, Poland, Guyana, Sri Lanka
Co-Investigator(s):
Adam S Freeman, Alex G Kalugin, Alexis R Ajello, Alice A Blair, Alicia M Frees, Alphonso A Haupt, III, Amanda N Schaupp, Andersoneric, Andrew B Slarve, Andrew E Kay, Andrew T Todd, Angel K Sandhu, Angela D Wise, Anna J Vickrey, Anna L Marroquin, Anna L Viveros Hernandez, Anne E Carpenter, Annie H Lam, Anthony E Keller, RPh, Arturo De La Garza, Ashar P Parikh, Ashley N Williams, Benny Y Gong, Blair, Brandi N Mcgrady, Brant M Schroeder, Brenna L Macdowell, Brent W Higgs, Brett W Podoski, Brian R Yaun, Bruce D Broidy, Capri R Woolridge, Carlos A Ortiz, Carr, Celeste K Wong, Chan, Chloe Anne K Le, Chloe Anne Leong, Christine L Williams, Christopher J Lee, Chyla T Hunter, Cindy W Lewis, Clara E Santiago, Courtney R Bolton, Courtney R Tiegs, Courtney R Warren, Damon A Growl, Daniel C Geffin, Daniel J Gorski, Daniel J Roberts, Daniel Velasquez, Dariusz Galezowski, Darla R Bracy, David A Laplante, David A Lum, David J Leray, David P King, David R Heiar, Davina M Martinez, Deborah W Hsu, Debra D Devlieger, Debra L Curtis, Deidre R Edwards, Dena L Jacobs, Devon M Shoop, Dhaval H Patel, Dipesh K Shah, Dirk L Lincoln, Dustin P Tran, Edith M Gonzalez, Edna J Hidalgo, Edward D Harris, Edwards, Elizabeth D Connell, Elizabeth P Mayer, Elodie Xtong Lin, Elsa Y Yu, Emal Wahab, Erica L Nicoll, Erica R Pomeroy, Erin L Nagel, Estefania Fernandez, Eva I Merced Medina, Frank P Bianco, Gale L Glinecki, Gillenwater, Glen E Harelson, Grant L Davis, Greg K Keshishyan, Harmon M Blanch, Helen J Hamaoka, Herbert E Arden, Humberto Z Gomez, Hung V Le, Ismael Garibay, James A Lane, James C Yee, James E Trabert, Jane Chen, Janice R Small, Janice Wai, Jason P Aun, Jeff M Uriarte, Jeffrey W Shrifter, DPM, Jennifer A Baker, Jennifer A Bazergui, Jennifer Crumb, Jennifer L Johnson, Jennifer Macmillan, Jennifer S King, Jessica B Darneille, Jessica D Weber, Joan T Briones, Joanne M Fukuda, Jocelyn T Ramos, John A Liu, Jolene S Hedgecock, Jon C Polzine, Jonathan A Womack, Jonathan T Little, Jorge L Bertran, Joseph A Seitz, Joseph M Willems, Joseph S Fanelli, Joseph T Dougherty, Joseph Tibay, Juan A Morales, Justin A Hefferman, Kacie M Crowther, Karen D Phung, Karl D Hezel, Karla J Gibler, Kathryn A Guardiola, Kathryn G Brown, Kathryn M Mogen, Kavita K Lalwani, Kawshalya Pathiraja, Kay M Vialpando, Kendra L Brooks, Kevin T Gerrity, Kibily D Dembele, Krystina M Jackson, Lakecha N Lewis, Larisa E Pavlick, Larkin R Buckalew, LCDR Jennifer H Rhyu, Lea Lakes, Lealand Lee, Lee, Leongc, Lesley A Swanson, Leslie A Mendoza, Ligia M Cline, Ligia M Sanders, Lillyj, Linda S Shook, Lisa A Bowden, Lisa H Nakagawa, Liu, Lopez, Lorenzo F Edwards, Lorraine N Williams, LT Mark A Chen, MPH, Lydia S Chan, Mabel M Lee, Macropolk, Margaret N Persich, Margo Cl Jones, Maridali De Leon Torres, Marissa J Chan, Mark I Nakano, Mark L Collins, Mary C Wall, Mary M Finn, Maxyne T Lam, Mcgrewp, Megan E Kulas, Michelle L Tripp, Miguel G Manzano, Mikhail V Ovanesov, PhD, Mohammed H Adam, Natalie J Ayoub, Neal D Singletary, PhD, Nicholas P Schaub, Nicole J Clausen, Nicole Yuen, Nympha V Florendo, Pablo Alcantara, Paola E Lathrop, Patrick E Gainer, Pedro A Cruz, Phal K Chhun, Phung, Quynh H Strandberg, Randall J Plunkett, Randy L Elsberry, Rebecca A Coleman, Rene M Amaguana, Richard G Fochesato, Robert J Vezzetti, Robert T Lorenz, Robert W Calais, Rocio Guzman Velazquez, Roger D Gawne, Ronald P Boyce, Roy C Stephens, Rumany C Penn, PharmD, Said H Muse, Sandra S Saniga, Sara Jdent Acosta, Sean P Desbrow, Seema S Singh, Seyyida Saterfield, Sharon L Shane, Shelley H Beausoleil, Shelley H Roberts, Siobhan A Gallagher, Sondra R Davis, Sonia D Hudson, State Agency, Stephanie Mangigian, MS/OSH, RN, Steven B Chiu, Steven C Himebaugh, Steven M Galvez, Stuart W Russell, Tara M Mussatto, Terrence Gee, Theresa L Stewart, Thomas J Hudson, Thomas N Adjabeng, Thomas Siebertz, Thomas W Nerney, Timothy C Grome, Tomanik'e C Banks, Travelle D Mason, Tressa T Lewis, Tristian E Strait, Vi T Au, Victoria Taylor, Wayne L Jefferson, Wen Jun Peng, William G Nelson, William J Foust, William J Weis, William V Millar

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more